PHIO
Phio Pharmaceuticals Corp.
NASDAQ · Healthcare · Biotechnology · US
$1.03
+0.98%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.36
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.36
- EPS estimate
- -$0.36
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +4.1%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.36 | -$0.36 | In line | — |
| May 7, 2026 | -$0.24 | -$0.34 | Miss -41.67% | — |
| Mar 5, 2026 | -$0.34 | -$0.15 | Beat 55.88% | — |
| Nov 13, 2025 | -$0.45 | -$0.44 | Beat 2.22% | — |
| Aug 14, 2025 | -$0.36 | -$0.45 | Miss -25.00% | — |
| May 15, 2025 | — | -$0.41 | — | — |
| Mar 31, 2025 | -$1.23 | -$0.85 | Beat 30.89% | $70.0K |
| Nov 14, 2024 | -$4.14 | -$1.54 | Beat 62.80% | — |
| Aug 14, 2024 | -$4.59 | -$3.62 | Beat 21.13% | — |
| May 9, 2024 | — | -$4.23 | — | — |
| Nov 9, 2023 | -$13 | -$10 | Beat 20.28% | — |
| Aug 10, 2023 | — | -$13 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026